The expression pattern of the imprinted human H19 gene was investigated in testicular cancers of dierent etiology, as well as in normal testicular parenchyma, parenchyma without germ cells, and adjacent to testicular germ cell tumors of adolescents and adults (TGCTs), using RNase protection analysis, mRNA in situ hybridization and reverse-transcription polymerase chain reaction. While dierent total expression levels were detected in spermatocytic seminomas, lymphomas, a Sertoli cell tumor and Leydig cell tumors, none showed a disturbance of monoallelic expression. Strikingly, the majority of invasive TGCTs revealed expression of both parental alleles. The total level of expression highly correlated with dierentiation lineage and stage of maturation, similar to that as reported during early normal embryogenesis. Biallelic expression could also be determined speci®cally in testis parenchyma containing the preinvasive lesion of this cancer. We therefore conclude that within the adult testis, biallelic H19 expression is speci®c for TGCTs, and that the level of expression is dependent on dierentiation lineage and maturation stage. This is in agreement with the proposed primordial germ cell-origin of this cancer, and might be related to retention of embryonic characteristics in TGCTs. In addition, our data argue against H19 being a tumor suppressor gene.
Introduction
Genomic imprinting, de®ned as the functional difference between homologous mammalian chromosomal regions due to their parental origin (Solter, 1988; De Groot and Hochberg, 1993) , has become a major ®eld of interest. Multiple studies have indicated large impact of this phenomenon on embryonic development and pathological, both non-neoplastic and neoplastic, conditions (Hall, 1990; Solter, 1992; Feinberg, 1993; Tycko, 1994) . It was shown that normal embryogenesis depends on a proper balance between the paternal and maternal copy of certain chromosomal regions Fundele and Surani, 1994) . Relative gain of maternal (parts of) chromosomes results in preferential growth of somatic elements, while overrepresentation of paternal (parts of) chromosomes favors trophoblast formation. In evolutionary terms, this was interpreted as a strife between the interests of the individual and the species (Moore and Haig, 1991) . In addition, existence of genomic imprinting results in non-viability of digynic (consisting of two haploid sets of maternally derived chromosomes) and diandric (consisting of two haploid sets of paternally derived chromosomes) embryo's and renders sexual reproduction a necessity, which is bene®cial to the species.
A number of human genes are subject to genomic imprinting (Reed and Le, 1994; Latham, 1995) , ie., showing a uniparental pattern of expression. One of these genes, H19, expressed preferentially from the maternal allele, shows a de®ned pattern of expression during embryonal development (Rachmilewitz et al., 1992a; Mutter et al., 1993; Lustig et al., 1994; Ohlsson et al., 1994; Svensson et al., 1995; Walsh et al., 1995) . In mice, overexpression of H19 leads to intra-uterine death (Brunkow and Tilghman, 1991) , while the complete absence of expression seems to have no deleterious eect (Leighton et al., 1995a) . H19 most probably acts as an RNA (Brannan et al., 1990) and multiple functions have been suggested, including regulation of the closely apposed and reciprocally imprinted insulin-like growth factor 2 gene (Bartolomei et al., 1993; Leighton et al., 1995a,b) , thereby possibly linked to its supposed action as a tumor suppressor Moulton et al., 1994; Steenman et al., 1994; Taniguchi et al., 1995) , and as a so-called oncofetal gene Lustig et al., 1994; Rachmilewitz et al., 1995) . Biallelic expression of H19 has been found in a certain percentage of human cancers (Zhang et al., 1993; Moulton et al., 1994; Van Gurp et al., 1994; Steenman et al., 1994; Elkin et al., 1995; Kondo et al., 1995; Taniguchi et al., 1995; Walsh et al., 1995; Douc-Rasy et al., 1996; Hibi et al., 1996) , referred to as relaxation or loss of imprinting (LOI), which may be accompanied by up-and downregulation of the total level of expression.
Genomic imprinting is determined by the sex of the individual, and the paternal (during spermatogenesis) or maternal (during oogenesis) pattern has to be fully present in mature germ cells. Therefore, erasement and the subsequent formation of a uniparental pattern of genomic imprinting has to be established during development of a primordial germ cell to a mature gamete (Rossant, 1993) . Somewhere in this process, the precursor of all testicular germ cell tumors of adolescents and adults (TGCTs), i.e., carcinoma in situ, is initiated (Skakkebaek et al., 1987; Jùrgensen et al., 1995) . Histologically, TGCTs mimick early embryogenesis, and can be divided into seminomas, tumors showing similarities with early (primordial?) germ cells, just like carcinoma in situ and nonseminomatous-TGCTs, which can be composed of somatic (embryonal carcinoma and teratoma) as well as extraembryonic (yolk sac tumor and choriocarcinoma) elements (Mosto® et al., 1987) . Embryonal carcinoma cells are the stem cells for the more dierentiated nonseminomatous-TGCT-components, i.e., teratoma, yolk sac tumor, and choriocarcinoma (Goodfellow and Andrews, 1982) . So-called embryoid bodies, structures analogous to a developmental stage of 10 days post coitum, can be found in nonseminomatousTGCTs (Nakashima et al., 1988) . Besides TGCTs, spermatocytic seminomas also originate from a cell belonging to the germ cell lineage, most probably spermatogonia-B (Romanenko and Persidskii, 1983; Talerman et al., 1984; Dekker et al., 1992; Burke and Mosto®, 1993; Cummings et al., 1994; Eble, 1994) . In addition, non-germ cell-derived tumors of dierent histogenesis can develop in the male gonad, including lymphomas, Leydig cell and Sertoli cell tumors.
Analysis of H19 expression (mono-or biallelic/total level/histological heterogeneity) in the germ cell-and non-germ cell-derived cancers might reveal new insights in the possible role of genomic imprinting in general, and of H19 in particular, in the development of these cancers of the testis.
Results

RNase protection analysis
H19 expression levels (with the expression of g-actin used as a reference, see Methodology) within the series of testicular non-germ cell tumors analysed are shown in Figure 1a . No expression was detected in three out of four B-cell lymphomas and in two out of three spermatocytic seminomas. One B-cell lymphoma (Lym 4B ) and one spermatocytic seminoma (SS 3 ) showed a very low expression. A low to moderate expression was present in the T-cell lymphoma and both Leydig cell tumors. The only Sertoli cell tumor studied showed a high expression. A low expression was present in normal testis parenchyma.`Low, moderate and high' expression are de®ned as described in the legend of Table 1 .
Of the TGCTs, low H19 expression was detected in all 24 seminomas tested (Figure 1b) , within the range of 0.03 and 0.34 times the intensity of the actin signal, with a mean of 0.16 (standard deviation 0.09). We did not observe dierences between seminomas without and with hCG (human Chorionic Gonadotropin)-positive mononuclear cells (depicted by a (+) in Figure 1b ). Concerning H19 expression in nonseminomatous-TGCTs, three dierent groups can be identi®ed ( Figure 1c and Table 1) . A low expression was present in the ®rst four cases. Three were diagnosed as pure embryonal carcinoma (cases 1, 2 and 3), and one as embryonal carcinoma/yolk sac tumor (case 4). Tissue slides used for veri®cation of the histological composition of the samples used for RNA isolation, demonstrated that also case 4 contained mainly embryonal carcinoma (not shown). These data suggest that both seminomas and embryonal carcinoma show a comparable and consistent low expression of H19.
A moderate expression was identi®ed in cases 5 ± 10. The lowest expression was found in case 6, which contained only mature teratoma. Moderately low expression was found in case 8, containing mainly embryonal carcinoma. All other samples consisted of the dierent histological elements in approximately similar amounts. High expression was present in the last three cases (cases 11 ± 13). The ®rst contained mainly immature teratoma, the second both mature teratoma and choriocarcinoma, and the last mainly immature teratoma. These results suggest that H19 is preferentially expressed in immature teratoma and choriocarcinoma, and less in mature teratoma. To study this in more detail, mRNA in situ hybridization was performed.
mRNA in situ hybridization
No signals were found by mRNA in situ hybridization on routinely included controls in every experiment, i.e., sense probe and RNase treated tissue sections using the antisense-probe (not shown). Expression of H19 mRNA was found in the Leydig cell tumors and the Sertoli cell tumor (Figure 2a and b) . No expression of H19 was present in their non-malignant counterparts or other cell types in normal testis and in testicular parenchyma adjacent to a TGCT (not shown). The (low) expression found in normal testes using RNase protection analysis (and RT ± PCR) can therefore not speci®cally be attributed to one of the cell types present. No expression was detected in B-and T-cell lymphomas, two spermatocytic seminomas (SS 3 was not studied with mRNA in situ hybridization), and seminomas with or without hCG-positive mononuclear cells (Figure 2c and d) . Also no expression was detected using mRNA in situ hybridization in All dierent histological nonseminomatous-TGCTelements could be analysed in independent cases and showed no dierences whether pure or mixed with other components. Twenty-one dierent embryonal carcinoma components (including all pure cases) could be scored, showing no H19 expression in the tumor cells, while expression was detected in the stromal elements (Figure 2e and f). One pure teratoma and 15 teratoma-components of mixed nonseminomatousTGCTs could be analysed. The immature glandular, squamous and respiratory epithelium and cartilage showed strong expression of H19 (Figure 2g and h) , while smooth muscle cells and neural elements were negative. Also no expression was found in embryoid bodies (Figure 2i and j) . While the majority of mature teratoma elements lacked H19 expression, three cases (one mixed with embryonal carcinoma, one with embryonal carcinoma/yolk sac tumor and one with yolk sac tumor) showed expression of this gene in some regions (not shown). H19 expression was also found in three residual masses diagnosed as containing mature and no immature teratoma (one mixed with embryonal carcinoma, one with choriocarcinoma and one with yolk sac tumor). Prominent expression of H19 was present in choriocarcinoma and in all trophoblastic giant cells (not shown), as well as in the reticular areas of yolk sac tumor (Figure 2k and l). No expression was present in Schiller Duval bodies (Figure 2m and n).
Reverse-transcription polymerase chain reaction (RT ± PCR)
In contrast to RNase protection analysis and mRNA in situ hybridization, RT ± PCR allowed us to detect H19 expression in three B-cell lymphomas out of four cases tested ( Figure 3 ). One (case 2) remained negative, just as the bilateral spermatocytic seminomas (SS 1 and SS 2 ). The expression found by RNase protection in one Bcell lymphoma and one spermatocytic seminoma (not detectable using mRNA in situ hybridization) was con®rmed by RT ± PCR ( Figure 3a , Lym 4 B and SS 3 ). RT ± PCR also con®rmed H19 expression in all other tumors showing a low, moderate or high expression using RNase protection analysis. In addition, RT ± PCR showed H19 expression in four samples of normal testicular parenchyma (Figure 4a ), as well as in seven testicular parenchyma samples without germ cells (not shown). By making use of a polymorphic RsaI site in exon 5 of the H19 gene (Zhang and Tycko, 1992) , it was possible to analyse whether H19 was expressed mono-or biallelically in one normal testis, two testes without germ cells, one spermatocytic seminoma (SS 3 ), one B-cell lymphoma (Lym 1B ) and two Leydig cell tumors. Expression was found to be monoallelic in all cases ( Figure 3b and c, Figure 4b and c). The origin of the expressed allele could not be determined because parental blood was not available for analysis. Three normal semen samples showed no H19 expression, while HPRT (Hypoxanthine-Phospho-Ribosyl-Transferase)-transcripts were present, illustrated in Figure 5 .
Within the series of seminomas and nonseminomatous-TGCTs studied by RNase protection analysis, 13 seminomas and seven nonseminomatous-TGCTs were informative for the RsaI site (representative examples are illustrated in Figure 6a , upper panel). All seminomas showed biallelic expression, as well as most nonseminomatous-TGCTs ( Figure 6a , lower panel). In addition to this series, 30 nonseminomatous-TGCTs with dierent histological compositions were studied. Of these, seven out of nine informative Figure 1b) showed a DNA ratio of 1 : 0.5 and a six times higher expression of the underrepresented allele ( Figure 6b ). Out of nine informative primary nonseminomatous-TGCTs tested quantitatively, seven showed a near 1 : 1 ratio of alleles at the DNA level. The calculated expression per allele of six of these varied between 1 : 1 and 1 : 2. One nonseminomatous-TGCT (case 1 in Figure 1c ) showed strong preferential expression from one allele (Figure 7a ). Two other (1856) with expression mainly in stromal elements (/1) and in respiratory epithelium (/2); (i and j) embryoid body (3006) with absence of expression in the embryoid body itself (/1) and strong expression in the reticular stroma (/2); (k and l) yolk sac tumor (1856) with prominent expression in the reticular areas (arrows); (m and n) characteristic Schiller-Duval body (1856) nonseminomatous-TGCTs (cases 5 and 7) showed monoallelic expression, and a strong overrepresentation of the expressed allele at DNA level (Figure 7b ). Analysis of DNA isolated from peripheral blood from the patient of case 5 and both his parents showed that the expressed, and overrepresented, allele is of paternal origin. A metastasis found in one of the retroperitoneal lymph nodes after intensive chemotherapeutic treatment, containing only mature teratoma, showed a 1 : 1 ratio of the H19 alleles at the DNA level. Interestingly, in contrast to the primary tumor, only the maternal allele was found to be expressed. These results are illustrated in Figure 7c .
To study H19 expression in the preinvasive stage of TGCTs, RNA was isolated from testis parenchyma samples containing various amounts of carcinoma in situ cells. All testicular parenchyma samples adjacent to a TGCT without carcinoma in situ cells (n=6) showed monoallelic expression, in agreement with normal testis parenchyma samples. Of 14 samples containing variable amounts of carcinoma in situ (8 ± 100% of the seminiferous tubules), nine contained detectable biallelic expression, with one allele clearly overexpressed, in spite of a 1 : 1 ratio of the alleles at DNA level (Figure 8 ). This indicates that the bulk of H19-transcripts present is expressed from the host tissue, which shows monoallelic expression. The remaining cases showed monoallelic expression of H19. Parental blood was not available of these samples to test parental origin of the expressed allele(s).
The results obtained by RNase protection analysis, mRNA in situ hybridization and/or RT ± PCR are summarized in Table 2 .
Discussion
To gain more insight into the role of genomic imprinting in the development of testicular cancers of dierent etiology, we performed an extensive screening for H19 expression using RNase protection analysis, mRNA in situ hybridization and RT ± PCR. The results of these techniques were found to be in agreement and complementary to each other and allowed a detailed analysis of total level, mono-or biallelic pattern, as well as tissue distribution of H19 expression.
Low or no expression of H19 was found in testicular lymphomas. In this context, it is noteworthy that we and others (Steenman et al., 1994; were not able to detect H19 expression in peripheral blood. Therefore, it would be interesting to analyse whether H19 is expressed in hematopoietic stem cells. Malignant Sertoli and Leydig cells show a moderate to high expression. It remains to be studied whether the expression found in normal and germ cell-devoid testis parenchyma and parenchyma adjacent to a TGCT is due to H19 transcription in Sertoli and/or Leydig cells, or is (also) due to other cell types present. The ®nding of H19 expression in testicular parenchyma devoid of germ cells indicates that expression of this gene is at least not restricted to the germ cell compartment. Because all informative cases showed monoallelic expression of H19, LOI of this gene is not involved in the pathogenesis of these cancers.
Both carcinoma in situ and seminomas show characteristics of early (primordial?) germ cells and are thought to be derived from these cells (Skakkebaek et al., 1987; Jùrgensen et al., 1993 Jùrgensen et al., , 1995 Rajpert-De Meyts and Skakkebaek, 1994) . Because of the ®nding of biallelic expression of imprinted genes, including H19, in murine primordial germ cells (Szabo and Mann, 1995) , the biallelic expression as found in carcinoma in situ-containing testicular parenchyma adjacent to an invasive TGCT, as well as in seminomas, is therefore not unexpected. To investigate whether lack of biallelic expression of H19 in the minority of carcinoma in situ-containing parenchyma samples is due to the limited sensitivity of the method used, will be veri®ed using isolated populations of carcinoma in situ. The expression of H19 alleles in a 1 : 1 ratio in the majority of nonseminomatous-TGCT is disconcordant with the ®nding of leakage of imprinted genes in murine parthenogenetic and androgenetic embryonic stem cell lines (Szabo and Mann, 1994) , and seems to be in contradiction to the ®nding of monoallelic expression of H19 during early murine development (Sasaki et al., 1995) . This is most probably due to the fact that at the developmental stages included in the latter study, primordial germ cells (and thus biallelic expression of imprinted genes) are hardly present. Most interestingly, however, the ®nding of monoallelic expression of the maternal allele of H19 in a residual mature teratoma, in contrast to preferential expression of the overrepresented and paternal allele in the primary tumor, suggests a similar phenomenon as reported in dierentiating parthenogenetic and androgenetic stem cells (Feil et al., 1994) , showing ®nal functional establishment of genomic imprinting upon dierentiation. Speci®cally, this indicates that the parental alleles of H19 in TGCTs can still be distinguished from each other, in agreement with the ®nding of preferential loss of the paternal copy of the short arm of chromosome 11 in some TGCTs (Lothe et al., 1993) , not compatable assuming complete erasement of genomic imprinting. Overall, these data suggest that retention of biallelic expression of H19 in TGCTs is due to an intrinsic characteristic of the cell of origin, i.e., carcinoma in situ, being the malignant counterpart of an early (primordial?) germ cell. In addition, the lack of establishment of monoallelic expression of H19 might be related to the retention of the embryonic characteristics of TGCTs. In spite of a consistent biallelic expression of H19 in TGCTs, RNase protection analysis and mRNA in situ hybridization revealed a striking correlation between total level of H19 expression, dierentiation lineage and maturation stage, highly similar to the pattern as reported during normal embryogenesis (Rachmilewitz , 1992a,b; Mutter et al., 1993; Lustig et al., 1994; Ohlsson et al., 1994; Ariel et al., 1995; Svensson et al., 1995; Walsh et al., 1995) . While strong expression was detected in some immature somatic elements of nonseminomatous-TGCTs, as well as in choriocarcinoma and in reticular areas of yolk sac tumor, low expression was present in seminomas and embryonal carcinoma, similar to primordial germ cells (Szabo and Mann, 1995) and embryonal stem cells Szabo and Mann, 1994) . These data imply, that H19 might be a putative marker to identify immature teratomatous as well as early dierentiation of yolk sac tumor-elements in TGCTs. The additional ®nding of H19 expression in morphologically mature teratoma elements could indicate the presence of immature elements and thus might have clinical implications, which serves further investigation. That H19 expression can indeed be of clinical importance was recently reported by us for bladder cancer, where a stronger and biallelic expression was found in cancers with a more malignant behavior Elkin et al., 1995; Cooper et al., 1996) . The ®nding of H19 expression in stromal elements as part of embryonal carcinoma and yolk sac tumor, as well as in stromal components surrounding the embryoid body is of special interest. Similar ®ndings have been reported in breast cancer (Dugimont et al., 1995) . A regulatory role for H19 in proliferation and dierentiation of both normal and malignant cells might therefore be suggested, as found for stromal elements in general (Donjacour and Cunha, 1991; Bosman et al., 1993; Howlett and Bissell, 1993) . In conclusion, the pattern of H19 as found in the testicular cancers of dierent etiology included in this survey, as well as in cell lines (Rachmilewitz et al., 1995) and normal development contradicts the supposed tumor suppressor function of this gene , but, in contrast, suggests a dierentiation-lineage and maturation stage-speci®c pattern of expression. This is in agreement with the proposed oncofetal properties of this gene (Rachmilewitz et al., 1992b; Biran et al., 1994; Lustig et al., 1994) . The process of erasement of genomic imprinting, which occurs during germ cell maturation, and the ®nal establishment of a new imprint, is not well understood. It is still a matter of debate whether both the maternal and paternal imprint are erased, or only the imprint of the opposite sex (Rossant, 1993) . In this context the spermatocytic seminomas are of particular interest. Monoallelic expression of H19 found in the only informative tumor indicates that at this developmental stage of spermatogenesis the maternal and paternal allele can still be distinguished from each other, in agreement with data from mice (Szabo and Mann, 1995) . This again supports the hypothesis that in early germ cells (and malignant counterparts and derivatives) biallelic expression of imprinted genes is not due to erasement, but a result of functional ignorance of the non-equivalence of the parental alleles. The lack of H19-transcripts in semen (this paper) might be due to the ®nal establishment of a uniparental pattern of genomic imprinting in these mature germ cells, or may be due to cell type-speci®c inactivity. However, the lack of H19 expression in two spermatocytic seminomas (contralateral cases of one patient) and low expression in the third suggests that inactivation of the H19 gene might indeed be established around this stage of germ cell maturation. Our hypothesis regarding the status of genomic imprinting in germ cells at dierent stages of their maturation, as well as their malignant counterparts and derivatives, is schematically illustrated in Figure 9 .
In conclusion, we illustrated that LOI of H19 is not a general event in the pathogenesis of testicular cancers. However, biallelic expression was detected in the majority of TGCTs, with an expression pattern Figure 9 Schematic representation of the model of H19 expression at dierent stages of male germ cell development and their possible malignant counterparts and derivatives resembling normal embryogenesis. We hypothesize that this is due to functional ignorance of the nonequivalence of the parental alleles of H19 in primordial germ cells, which is retained in their malignant counterparts (carcinoma in situ) and derivatives (seminomas and nonseminomatousTGCTs).
Materials and methods
Tissue samples
The testicular tumors were collected at the Laboratory of Experimental Patho-Oncology in close collaboration with pathologists and urologists in the South-Western part of the Netherlands. Representative parts of the tumor and the adjacent parenchyma (when available) were snap frozen in liquid nitrogen (for DNA and RNA isolation) as well as ®xed in 4% buered formalin overnight at room temperature, and subsequently embedded in paran. The TGCTs were classi®ed according to the World Health Organization recommendations (Mosto® et al., 1987) , while the Working Formulation was used for lymphomas (Rosenberg et al., 1982) .
H19 probe and RNase protection analysis
A cDNA fragment of the human H19 gene (exon 5: position 3030 ± 3375) (Brannan et al., 1990) including the polymorphic RsaI site (position 3238) was cloned into SacI/SmaI digested PGEM-3Z plasmid (Promega). To generate the antisense probe, in vitro transcription of 1 mg of plasmid DNA, in the presence of [a-32 P]CTP was performed using Sp6 RNA polymerase after linearization of the plasmid with EcoRI. As control, a sense probe was generated similarly after linearization of the plasmid with HindIII and transcription using T7 RNA polymerase. As reference for the amount of RNA used for the analysis, a g-actin antisense probe was constructed as follows. A 129 bp HinfI/HindIII fragment (Enoch et al., 1986) was subcloned into the SmaI/HindIII site of the PGEM4Z plasmid (Promega). The antisense probe was generated by linearization of the plasmid with EcoRI and transcription with T7 RNA polymerase in the presence of [a- 32 P]CTP. Subsequently, template DNA was removed by adding 2.5 U of RQ1 DNase (Promega) for 20 min at 378C. The labeled probes were separated from the unincorporated nucleotides using the Quick Spin Columns Sephadex G50 (Boehringer Mannheim).
From each tumor total RNA was isolated from approximately 10 frozen tissue sections of 50 mm thickness each, using RNA STAT-60 (TEL-TEST). Of each sample, two 5 mm sections (the ®rst and the last in the series) were cut and stained with hematoxylin and eosin for microscopic analysis of the histological elements present. Five mg of RNA was used for the analysis using the Ribonuclease Protection Assay Kit, RPA II (Ambion) according to the manufacturer's description. After hybridization, the samples were treated with RNase (1 : 100) for 1 h at 378C. The samples were loaded onto a 6% polyacrylamide/8M urea gel, and electrophoresed for 3 h at a Voltage of 1800, after which the gel was vacuum-dried. Subsequently, exposure was performed to CEA RP ®lms (medical X-ray screen ®lm blue sensitive, Cea Corps) for various lengths of time at 7808C.
Interpretation of the autoradiographs was established using a videodensitometer (2600, Biorad) with appropriate software applications as recommended by the supplier. Within each lane, the relative intensity of the H19 signal was determined compared to that of the g-actin signal, after compensating for background signal. Due to the RNase conditions as used by us (optimalized for H19), the protected fragment of the actin signal is composed of three bands. The smallest band was used as reference in the calculations, as the intensity of this band always fell within the linear range and could be measured by the videodensitometer.
This analysis was performed on two normal testes, four Bcell lymphomas, one T-cell lymphoma (being a metastasis of a nodal lymphoma), one Sertoli cell tumor, two Leydig cell tumors, and three spermatocytic seminomas (two were contralateral sequential tumors of one patient). In addition, the following TGCTs were studied: 24 seminomas (11 contained hCG-positive mononuclear trophoblastic cells) and 13 nonseminomatous-TGCTs (these were diagnosed as three pure EC, one as EC/YS, one as TE (mature), one TE (mature)/CH, two EC/TE (mature), one EC/TE (mature and immature), one EC/TE (mature)/YS, and three EC/TE (mature and immature)/YS. Trophoblastic giant cells were found in two cases, one containing EC/YS/mature TE, and one EC/TE (mature and immature)/YS. H19 probe and mRNA in situ hybridization Part of the human H19 gene with a length of 800 base pairs (bp) was subcloned at the EcoRI restriction site into the Bluescript II KS plasmid (Stratagene, GMBH). After linearization of the plasmid, in vitro transcription was performed using T7 to produce the antisense H19 probe (plasmid linearized with HindIII), while T3 was used to produce the sense probe as control (plasmid linearized with EcoRI).
The in vitro generated transcripts were labeled with 35 S (107 c.p.m./mg) using a commercially available kit (RPN 2006, Amersham) with polymerases of Boehringer according to the manufacturer's recommendations. The labeled fragments were separated from unincorporated nucleotides by ethanol precipitation.
For mRNA in situ hybridization, 5 mm thick paran tissue sections were cut and mounted onto 3-aminopropyltriethoxylane (Tespa) (Sigma) coated microscope slides and dried overnight at 378C. RNase treated tissue sections as well as the sense probe were included as negative controls. Tissue sections were deparanized with xylene and post-®xed with 4% paraformaldehyde. Subsequently, the tissue sections were treated with proteinase K (Sigma), after which they were acetylated and dehydrated to reduce non-speci®c binding. Hybridization was performed as described Lustig et al., 1994) . The tissue sections were exposed at room temperature for 10 days, after which they were counterstained with hematoxylin-eosin-light green. Interpretation was done by microscopic analysis under bright and dark ®eld illumination by two pathologists individually.
The mRNA in situ hybridization was applied on 21 pure seminomas (®ve also studied by RNase protection analysis), 11 pure nonseminomatous-TGCTs (six EC, one TE, three YS, 25 mixed NS (one EC/TE, one TE/CH, one TE/YS/SE, one EC/SE, one EC/TE/SE, three EC/YS, three EC/TE/YS/ SE (one containing intratubular SE), three TE/YS, and 11 EC/TE/YS) (seven were also studied by RNase protection analysis). In addition, one Sertoli cell tumor, three Leydig cell tumors, two spermatocytic seminomas, ®ve centroblastic B-cell lymphomas and one T-cell lymphoma were investigated (one Leydig cell tumor and one B-cell lymphoma were not studied by RNase protection analysis). The T-cell lymphoma is most likely a metastasis from a nodal primary cancer. Embryoid bodies were detected in three NS, trophoblastic giant cells also in three, and Schiller Duval bodies in three YS. In addition, testis parenchyma was studied from eight adults (two normal, one adjacent to a Leydig cell tumor, two adjacent to a seminoma and ®ve adjacent to a NS). Immunohistochemistry con®rmed the presence of CIS in the adjacent parenchyma of the TGCTs (not shown). Six residual extragonadal masses (three TE, one EC/TE, one TE/CH and one TE/YS) after polychemotherapy because of a testicular NS were included in this survey.
First strand cDNA synthesis and PCR
For detection of H19 expression, 5 mg of total RNA, isolated as described above, was reverse transcribed. cDNA was generated at 378C for 2 h in a total volume of 40 ml containing 1 mM each dNTP (Pharmacia), 1 mM dithiothreitol, 1.2 mg random hexamer primers (d[N]6) (Pharmacia), 1.2 mg oligo d(T) primer d [T] 12-18 (Pharmacia), 4.5 U of RNasin (Pharmacia), 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 3 mM MgCl 2 and 1 ml of Superscript RNAse H 7 RT (BRL; 200 U/ml). For the subsequent PCR 2 ml was used.
Ampli®cations were performed using 2 ml of the RT reaction in a total volume of 50 ml containing 16Taq DNA polymerase buer with 1.5 mM MgCl 2 , 100 pM of each primer, 250 mM each dNTP and 1 U of Taq DNA polymerase (Promega). Two primer sets were used for ampli®cation of H19, HN7 and HN8, spanning intron 2 and 3 (DNA fragment 542 bp, cDNA fragment 371 bp), and HN9 and HN10, spanning intron 3 and 4 (DNA fragment 949 bp, cDNA fragment 788 bp). Primer positions are: forward primer HN7 (5'-CCAGGTCTCCAGCTGGGG-TG-3') and reverse primer HN8 (5'-CTTCCAGAGCC-GATTCCTCAGT-3') derived from positions 2253 ± 2272 and 2773 ± 2794; and forward primer HN9 (5'-ACTTCCTC-CAGGGAGTCGGCA-3') and reverse primer HN10 (5'-TGATGATGAGTCCAGGGCTC-CT-3') derived from positions 2526 ± 2546 and 3453 ± 3474 of the published H19 sequence (which was renumbered by us, starting at one at the beginning of the published sequence (Brannan et al., 1990) ). After an initial denaturation of 4 min at 948C, every ampli®cation cycle consisted (between 30 and 35 cycles) of 1 min at 948C, 2 min at 64 (HN7/8) or 668C (HN9/10), and 2 min at 728C. Hypoxanthine Phospho-Ribosyl-Transferase (HPRT) primers used were 243 and 244 (Gibbs et al., 1989) . PCR products were visualized on 2.5 ± 3% (50% regular and 50% NuSieve GTG (FMC) agarose gels stained with ethidium bromide.
The samples showing H19 expression were studied for informativity of the polymorphic RsaI restriction site in exon 5 (Zhang and Tycko, 1992) , contained within primerset HN9 and HN10. Therefore high molecular weight DNA was isolated from peripheral blood of the patient (when available), normal testicular parenchyma, or the tumor sample itself when no control tissue was available, using proteinase K-sodium dodecyl sulfate treatment followed by phenol-chloroform extraction and ethanol precipitation (Maniatis et al., 1982) . Again tissue sections were used to verify histological composition. Ampli®cation products (5 ± 10 ml were digested to completion with 40 U of RsaI endonuclease (Pharmacia). Heterozygous samples showed an uncleaved band of 949 bp, and cleaved bands of 714 bp and 235 bp. The matched tumor RNAs were judged as biallelic when the cDNA ampli®cation products after digestion showed the uncleaved 788 bp band as well as the cleaved 553 bp and 235 bp bands. Completion of digestions was tested by always including a sample homozygous for the allele with the RsaI site. In addition at least three independent digests were done for each sample. This protocol was applied to all testicular non-germ cell tumors, seminomas and nonseminomatous-TGCTs studied by RNase protection analysis. In addition, six seminomas and four nonseminomatous-TGCTs, two normal testis samples, seven testicular parenchyma without germ cells (after intensive hormonal treatment for sex-reversal), and three normal semen samples and 20 testicular parenchyma samples with variable numbers of carcinoma in situ containing seminiferous tubules were analysed.
For the quanti®cation of alleles by (RT ± )PCR heterozygous samples were digested with RsaI. For both DNA and cDNA only the two upper bands (the undigested upper allele and the largest band of the digested lower allele) were included in calculating ratios. For DNA, a measured ratio of the intensity of the bands with lengths of 949 bp (A dna ) and 714 bp respectively (B dna ) of 1 : 0.75 represents a 1 : 1 ratio of the alleles. The ratio of DNA alleles=A dna / B dna 61.3=x. For cDNA, in case of biallelic expression, a measured ratio of the intensity of the bands with lengths of 788 bp (A cdna ) and 553 bp (B cdna ) respectively of 1 : 0.7 represents equal amounts of RNA expression from both alleles. The ratio of expression of the alleles=A cdna / B cdna 61.43=y. The quotient of y/x indicates the relative amount of expression per parental allele (1=similar expression; 41=preferential expression from the upper allele; 51=preferential expression from the lower allele). In DNA samples from normal control tissues this resulted as expected in a near 1 : 1 ratio of both alleles. Optical densities of PCR products on ethidium bromide stained gels were measured using the Bio-pro®l 4.6 software from Vilberlourmat.
Abbreviations
CIS=carcinoma in situ; SE=seminoma; NS=nonsemino-matous-TGCT; EC= embryonal carcinoma; TE-teratoma; YS=yolk sac tumor; CH=choriocarcinoma.
